Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,535 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
FAK in Cancer: From Mechanisms to Therapeutic Strategies.
Chuang HH, Zhen YY, Tsai YC, Chuang CH, Hsiao M, Huang MS, Yang CJ. Chuang HH, et al. Among authors: tsai yc. Int J Mol Sci. 2022 Feb 2;23(3):1726. doi: 10.3390/ijms23031726. Int J Mol Sci. 2022. PMID: 35163650 Free PMC article. Review.
The clinical efficacy of Afatinib 30 mg daily as starting dose may not be inferior to Afatinib 40 mg daily in patients with stage IV lung Adenocarcinoma harboring exon 19 or exon 21 mutations.
Yang CJ, Tsai MJ, Hung JY, Lee MH, Tsai YM, Tsai YC, Hsu JF, Liu TC, Huang MS, Chong IW. Yang CJ, et al. Among authors: tsai mj, tsai yc, tsai ym. BMC Pharmacol Toxicol. 2017 Dec 13;18(1):82. doi: 10.1186/s40360-017-0190-1. BMC Pharmacol Toxicol. 2017. PMID: 29237484 Free PMC article.
Better Progression-Free Survival in Elderly Patients with Stage IV Lung Adenocarcinoma Harboring Uncommon Epidermal Growth Factor Receptor Mutations Treated with the First-line Tyrosine Kinase Inhibitors.
Tsai MJ, Hung JY, Lee MH, Kuo CY, Tsai YC, Tsai YM, Liu TC, Yang CJ, Huang MS, Chong IW. Tsai MJ, et al. Among authors: tsai yc, tsai ym. Cancers (Basel). 2018 Nov 13;10(11):434. doi: 10.3390/cancers10110434. Cancers (Basel). 2018. PMID: 30428509 Free PMC article.
Targeting Pin1 for Modulation of Cell Motility and Cancer Therapy.
Chuang HH, Zhen YY, Tsai YC, Chuang CH, Huang MS, Hsiao M, Yang CJ. Chuang HH, et al. Among authors: tsai yc. Biomedicines. 2021 Mar 31;9(4):359. doi: 10.3390/biomedicines9040359. Biomedicines. 2021. PMID: 33807199 Free PMC article. Review.
Different Tyrosine Kinase Inhibitors Used in Treating EGFR-Mutant Pulmonary Adenocarcinoma with Brain Metastasis and Intracranial Intervention Have No Impact on Clinical Outcomes.
Kuo CY, Tsai MJ, Hung JY, Wu KL, Tsai YM, Tsai YC, Chuang CH, Lee TH, Chen HC, Yang CJ, Chong IW. Kuo CY, et al. Among authors: tsai mj, tsai yc, tsai ym. Cancers (Basel). 2022 Dec 28;15(1):187. doi: 10.3390/cancers15010187. Cancers (Basel). 2022. PMID: 36612183 Free PMC article.
1,535 results